(Q22250891)

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724479

29 December 2023

1 reference

1 reference

6

Ruth Lynfield

Ruth

Lynfield

1 reference

7 February 2023

13

Anne Schuchat

Anne

Schuchat

1 reference

7 February 2023

1

Cynthia G. Whitney

Cynthia G

Whitney

1 reference

7 February 2023

2

Monica M. Farley

Monica M

Farley

1 reference

7 February 2023

5

Nancy M. Bennett

Nancy M

Bennett

1 reference

7 February 2023

4

Lee H. Harrison

Lee H

Harrison

1 reference

7 February 2023

7

Arthur Reingold

Arthur

Reingold

1 reference

7 February 2023

3

James Hadler

James

Hadler

1 reference

7 February 2023

8

Paul R. Cieslak

Paul R

Cieslak

1 reference

7 February 2023

9

Tamara Pilishvili

Tamara

Pilishvili

1 reference

7 February 2023

10

Delois Jackson

Delois

Jackson

1 reference

7 February 2023

11

Richard R. Facklam

Richard R

Facklam

1 reference

7 February 2023

James H. Jorgensen

12

James H

Jorgensen

1 reference

7 February 2023

James Hadler

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724479

29 December 2023

Active Bacterial Core Surveillance of the Emerging Infections Program Network

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724479

29 December 2023

language of work or name

English

0 references

publication date

May 2003

0 references

1 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12724479

full work available at URL

29 December 2023

http://www.nejm.org/doi/pdf/10.1056/NEJMoa022823

1 reference

https://api.crossref.org/works/10.1056/NEJMOA022823

The New England Journal of Medicine

29 December 2023

published in

0 references

volume

348

0 references

page(s)

1737-1746

0 references

issue

18

0 references

cites work

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

https://api.crossref.org/works/10.1056/NEJMOA022823

2

1 reference

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

4

1 reference

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

5

1 reference

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

6

1 reference

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

7

1 reference

Carriage of pneumococci after pneumococcal vaccination

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

8

1 reference

Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

9

1 reference

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

10

1 reference

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

11

1 reference

Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

12

1 reference

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

15

1 reference

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

16

1 reference

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

17

1 reference

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

18

1 reference

Spread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of Types

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

19

1 reference

Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

21

1 reference

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

29 December 2023

https://api.crossref.org/works/10.1056/NEJMOA022823

22

1 reference